4725-84-2 Usage
Uses
Used in Pharmaceutical Industry:
1(2H)-Phthalazinone, 4-(3,4-dichlorophenyl)-2-methylis used as an intermediate for the synthesis of various drugs and pharmaceuticals, contributing to the development of new medications for different health conditions.
Used in Medicinal Chemistry Research:
1(2H)-Phthalazinone, 4-(3,4-dichlorophenyl)-2-methylis utilized in medicinal chemistry research for studying its potential biological activities and therapeutic uses in the treatment of various diseases, making it an important compound for advancing medical knowledge.
Used in Agriculture:
1(2H)-Phthalazinone, 4-(3,4-dichlorophenyl)-2-methylhas been found to possess insecticidal and pesticidal properties, making it a potential candidate for use in the agricultural industry to protect crops and enhance yield.
Check Digit Verification of cas no
The CAS Registry Mumber 4725-84-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,7,2 and 5 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 4725-84:
(6*4)+(5*7)+(4*2)+(3*5)+(2*8)+(1*4)=102
102 % 10 = 2
So 4725-84-2 is a valid CAS Registry Number.
4725-84-2Relevant academic research and scientific papers
Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
-
, (2008/06/13)
Aryl-fused- and hetaryl-fused-2,4-diazepines of formula XXXVI, benzodiazocines of formula XXX, benzodiazepines of formula II STR1 δ-aminoamides of formula III and aryldimethanamines of formula XXXVII STR2 wherein A is an aryl or hetaryl ring; R1 is hydrogen, alkyl, aryl or hetaryl; R2 is hydrogen, alkyl, substituted alkyl, or aryl; R3 is alkyl, aryl, aralkyl or heteroatom substituted alkyl or aralkyl; R4 is hydrogen or alkyl; R5 is hydrogen, alkyl, aryl or hetaryl; R6 is hydrogen, alkyl, alkoxy, halogen or a fused benzene ring; R9 is hydrogen, alkyl, or substituted alkyl; and R10 is hydrogen, alkyl, or substituted alkyl. The invention further relates to processes for the preparation of, pharmaceutical compositions containing, and methods of treating cardiac arrhythmia with the compounds of formulas XXXVI, XXX, II, III, and XXXVII.
